Petitioners To Board: Cancel Challenged Claims Of Vascular Stent Patent

(March 27, 2019, 1:17 PM EDT) -- ALEXANDRIA, Va. — In a March 26 petition for inter partes review (IPR), Abbott Vascular Inc. and two related Abbott entities (Abbott, collectively) and others assert that a claimed vascular stent...
To view the full article, register now.